P J Lustman

Summary

Affiliation: Washington University
Country: USA

Publications

  1. ncbi request reprint Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial
    P J Lustman
    Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110, USA
    Psychosom Med 59:241-50. 1997
  2. ncbi request reprint Depression and poor glycemic control: a meta-analytic review of the literature
    P J Lustman
    Department of Psychiatry, Washington University School of Medicine, and the Department of Veterans Affairs Medical Center, St Louis, Missouri, USA
    Diabetes Care 23:934-42. 2000
  3. ncbi request reprint Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial
    P J Lustman
    Department of Psychiatry, Washington University School of Medicine, and the Department of Veterans Affairs Medical Center, St Louis, Missouri 63110, USA
    Diabetes Care 23:618-23. 2000
  4. ncbi request reprint Association of depression and diabetes complications: a meta-analysis
    M de Groot
    Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA
    Psychosom Med 63:619-30. 2001
  5. ncbi request reprint The prevalence of comorbid depression in adults with diabetes: a meta-analysis
    R J Anderson
    Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA
    Diabetes Care 24:1069-78. 2001

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial
    P J Lustman
    Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110, USA
    Psychosom Med 59:241-50. 1997
    ..This investigation evaluated the effects of nortriptyline on depression and glycemic control to see whether depression in diabetes is treatable and whether restoring mental health contributes to improved medical outcome...
  2. ncbi request reprint Depression and poor glycemic control: a meta-analytic review of the literature
    P J Lustman
    Department of Psychiatry, Washington University School of Medicine, and the Department of Veterans Affairs Medical Center, St Louis, Missouri, USA
    Diabetes Care 23:934-42. 2000
    ..Depression is common among patients with diabetes, but its relationship to glycemic control has not been systematically reviewed. Our objective was to determine whether depression is associated with poor glycemic control...
  3. ncbi request reprint Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial
    P J Lustman
    Department of Psychiatry, Washington University School of Medicine, and the Department of Veterans Affairs Medical Center, St Louis, Missouri 63110, USA
    Diabetes Care 23:618-23. 2000
    ..It is associated with poor glycemic control and is linked to an increased risk for diabetic complications. In this study, we assessed the efficacy of fluoxetine for depression in patients with diabetes...
  4. ncbi request reprint Association of depression and diabetes complications: a meta-analysis
    M de Groot
    Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA
    Psychosom Med 63:619-30. 2001
    ..The objective of this study was to examine the strength and consistency of the relationship between depression and diabetes complications in studies of type 1 and type 2 adult patients with diabetes...
  5. ncbi request reprint The prevalence of comorbid depression in adults with diabetes: a meta-analysis
    R J Anderson
    Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA
    Diabetes Care 24:1069-78. 2001
    ..CONCLUSIONS--The presence of diabetes doubles the odds of comorbid depression. Prevalence estimates are affected by several clinical and methodological variables that do not affect the stability of the ORs...